Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT?

被引：10

作者：

Peggs, Karl S. ^{[1
]}

机构：

[1] UCL, Canc Inst, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England

来源：

BLOOD ADVANCES | 2018年 / 2卷 / 07期

关键词：

STEM-CELL TRANSPLANTATION; BRENTUXIMAB VEDOTIN; MARROW TRANSPLANTATION; EFFICACY; PEMBROLIZUMAB; NIVOLUMAB; SURVIVAL; BLOCKADE; OUTCOMES; FAILURE;

D O I：

10.1182/bloodadvances.2017011122

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：817 / 820

页数：4

共 19 条

[1] Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant [J].

Arai, Sally ;

Fanale, Michelle ;

deVos, Sven ;

Engert, Andreas ;

Illidge, Tim ;

Borchmann, Peter ;

Younes, Anas ;

Morschhauser, Franck ;

McMillan, Alex ;

Horning, Sandra J. .

LEUKEMIA & LYMPHOMA, 2013, 54 (11) :2531-2533

[2] Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure [J].

Armand, Philippe ;

Shipp, Margaret A. ;

Ribrag, Vincent ;

Michot, Jean-Marie ;

Zinzani, Pier Luigi ;

Kuruvilla, John ;

Snyder, Ellen S. ;

Ricart, Alejandro D. ;

Balakumaran, Arun ;

Rose, Shelonitda ;

Moskowitz, Craig H. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) :3733-+

[3] Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies [J].

Bartlett, Nancy L. ;

Chen, Robert ;

Fanale, Michelle A. ;

Brice, Pauline ;

Gopal, Ajay ;

Smith, Scott E. ;

Advani, Ranjana ;

Matous, Jeffrey V. ;

Ramchandren, Radhakrishnan ;

Rosenblatt, Joseph D. ;

Huebner, Dirk ;

Levine, Pamela ;

Grove, Laurie ;

Forero-Torres, Andres .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7

[4] Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma [J].

Chen, Robert ;

Zinzani, Pier Luigi ;

Fanale, Michelle A. ;

Armand, Philippe ;

Johnson, Nathalie A. ;

Brice, Pauline ;

Radford, John ;

Ribrag, Vincent ;

Molin, Daniel ;

Vassilakopoulos, Theodoros P. ;

Tomita, Akihiro ;

von Tresckow, Bastian ;

Shipp, Margaret A. ;

Zhang, Yinghua ;

Ricart, Alejandro D. ;

Balakumaran, Arun ;

Moskowitz, Craig H. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2125-+

[5] Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma [J].

Chen, Robert ;

Gopal, Ajay K. ;

Smith, Scott E. ;

Ansell, Stephen M. ;

Rosenblatt, Joseph D. ;

Savage, Kerry J. ;

Connors, Joseph M. ;

Engert, Andreas ;

Larsen, Emily K. ;

Huebner, Dirk ;

Fong, Abraham ;

Younes, Anas .

BLOOD, 2016, 128 (12) :1562-1566

[6] Brentuximab Vedotin Is Associated with Improved Progression-Free Survival after Allogeneic Transplantation for Hodgkin Lymphoma [J].

Chen, Robert ;

Palmer, Joycelynne M. ;

Tsai, Ni-Chun ;

Thomas, Sandra H. ;

Siddiqi, Tanya ;

Popplewell, Leslie ;

Faro, Len ;

Nademanee, Auayporn ;

Forman, Stephen J. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) :1864-1868

[7] Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma [J].

Herbaux, Charles ;

Gauthier, Jordan ;

Brice, Pauline ;

Drumez, Elodie ;

Ysebaert, Loic ;

Doyen, Helene ;

Fornecker, Luc ;

Bouabdallah, Krimo ;

Manson, Guillaume ;

Ghesquieres, Herve ;

Tabrizi, Reza ;

Hermet, Eric ;

Lazarovici, Julien ;

Thiebaut-Bertrand, Anne ;

Chauchet, Adrien ;

Demarquette, Helene ;

Boyle, Eileen ;

Houot, Roch ;

Yakoub-Agha, Ibrahim ;

Morschhauser, Franck .

BLOOD, 2017, 129 (18) :2471-2478

[8] Hodgkin Lymphoma Version 1.2017 [J].

Hoppe, Richard T. ;

Advani, Ranjana H. ;

Ai, Weiyun Z. ;

Ambinder, Richard F. ;

Aoun, Patricia ;

Bello, Celeste M. ;

Benitez, Cecil M. ;

Bernat, Karl ;

Bierman, Philip J. ;

Blum, Kristie A. ;

Chen, Robert ;

Dabaja, Bouthaina ;

Forero, Andres ;

Gordon, Leo I. ;

Hernandez-Ilizaliturri, Francisco J. ;

Hochberg, Ephraim P. ;

Huang, Jiayi ;

Johnston, Patrick B. ;

Kaminski, Mark S. ;

Kenkre, Vaishalee P. ;

Khan, Nadia ;

Maloney, David G. ;

Mauch, Peter M. ;

Metzger, Monika ;

Moore, Joseph O. ;

Morgan, David ;

Moskowitz, Craig H. ;

Mulroney, Carolyn ;

Poppe, Matthew ;

Rabinovitch, Rachel ;

Seropian, Stuart ;

Smith, Mitchell ;

Winter, Jane N. ;

Yahalom, Joachim ;

Burns, Jennifer ;

Ogba, Ndiya ;

Sundar, Hema .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (05) :608-638

[9] Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation† [J].

Martinez, C. ;

Canals, C. ;

Sarina, B. ;

Alessandrino, E. P. ;

Karakasis, D. ;

Pulsoni, A. ;

Sica, S. ;

Trneny, M. ;

Snowden, J. A. ;

Kanfer, E. ;

Milpied, N. ;

Bosi, A. ;

Guidi, S. ;

de Souza, C. A. ;

Willemze, R. ;

Arranz, R. ;

Jebavy, L. ;

Hellmann, A. ;

Sibon, D. ;

Oneto, R. ;

Luan, J. J. ;

Dreger, P. ;

Castagna, L. ;

Sureda, A. .

ANNALS OF ONCOLOGY, 2013, 24 (09) :2430-2434

[10] Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation [J].

Martinez, Carmen ;

Gayoso, Jorge ;

Canals, Carmen ;

Finel, Herve ;

Peggs, Karl ;

Dominietto, Alida ;

Castagna, Luca ;

Afanasyev, Boris ;

Robinson, Stephen ;

Blaise, Didier ;

Corradini, Paolo ;

Itala-Remes, Maija ;

Bermudez, Arancha ;

Forcade, Edouard ;

Russo, Domenico ;

Potter, Michael ;

McQuaker, Grant ;

Yakoub-Agha, Ibrahim ;

Scheid, Christof ;

Bloor, Adrian ;

Montoto, Silvia ;

Dreger, Peter ;

Sureda, Anna .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (30) :3425-+

← 1 2 →